Picture [LSUS] – The Business Web Portal 650x65px
Document › Details

Biofrontera AG. (2/4/14). "Press Release: Biofrontera AG – 4,438,292 Shares Placed in Capital Increase". Leverkusen.

Organisation Organisation Biofrontera AG
  Group Biofrontera (Group)
Products Product dermatic
  Product 2 finance
Index term Index term Biofrontera–SEVERAL: investment, 201401–201402 capital increase €15.3m net with 4.4m news shares

The board of directors of Biofrontera AG has resolved on 20 January 2014, to increase the registered capital of the company from currently EUR 17,753,168.00 by up to EUR 4,438,292.00 to an amount of up to EUR 22,191,460.00 by way of a capital increase against cash contribution by issuing up to 4,438,292 new registered no-par shares with an amount of the share capital attributable to each share of EUR 1.00 (“New Shares”) (see Ad-hoc-release of 20 January 2014). The shareholders were offered to subscribe to the New Shares and make offers for additional subscriptions. As of today’s assessment, all 4,438,292 New Shares were placed. The proceeds of the issue amount to approx. EUR 15.3 Million (net).

Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611


Biofrontera AG
Tel.: +49 (0214) 87 63 2 22, Fax.: +49 (0214) 87 63 290

Record changed: 2017-08-24


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Biofrontera (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSA] – The Business Web Portal 650x89px

» top